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In the last decades a body of information has been accu-
mulated to characterize the nature and incidence of errors 
in clinical laboratories. These studies led to further efforts 
to identify the steps of the testing process that are at high 
risk of errors and errors related to patient harm [1, 2]. This, 
in turn, paved the way for projects aiming to develop 
quality indicators specifically for the reduction of errors in 
clinical laboratories [3]. However, most of available data 
have been generated in clinical laboratories performing 
clinical chemistry, coagulation and hematology tests. The 
basic question is therefore “are collected data transferable 
to other types of clinical laboratories including microbiol-
ogy, cytology and surgical pathology”?
Recently, Nakhleh and colleagues suggested that “the 
test cycle in surgical pathology and cytology is similar 
to the test cycle of other laboratory tests” [4]. In fact, the 
testing process is always composed of the pre-analytic, 
analytic and post-analytic phases and although the brain-
to-brain loop model was developed specifically for labo-
ratory medicine, it is useful for describing the general 
process of diagnostic testing [5].
More recently, a careful exploration at the beginning 
and the end of the cycle prompted the proposal to split 
the pre-analytical steps into a “pre-pre-analytical” and a 
“true” pre-analytical phase, being the former the initial 
steps of the cycle performed before the biological sample 
enters into the clinical laboratory, while the “true” pre-
analytical phase includes all steps occurring within the 
laboratory in order to prepare the samples and ending 
when the analytical procedure begins. Analogously, the 
post-analytical steps are grouped into a “true” post-ana-
lytical phase consisting in procedures performed within 
the laboratory to validate the results, transforming the 
data into a report and finally communicate the report to 
the users. The “post-post-analytical phase” is represented 
by the steps that follows the report communication and 
takes into consideration the acknowledgment by the phy-
sician, the interpretation and utilization of the labora-
tory information [5]. Unlike the extra-analytical steps, the 
analytical phase is substantially different in some areas 
of laboratory medicine such as surgical pathology and 
microbiology in that it involves the inherent judgment 
of the professional at the time of the test interpretation. 
It is therefore more subjective than most clinical chem-
istry tests. This subjective nature makes it challenging 
to define errors in each phase and accurately document 
their incidence. Anatomic pathologists have documented 
the difficulty of establishing agreement on cause of errors 
in cancer diagnosis [6]. The Gram stain is an example of 
a microbiology test that requires interpretation by the 
medical laboratory technologist. The process of perform-
ing Gram stains may be manual or automated and the 
methods involved vary between laboratories but ulti-
mately the challenge remains in accurately reading and 
reporting Gram stains. This can complicated by a number 
of variables such as quality of the specimen, method of 
fixation, organism viability and inherent variations in 
staining of the organisms present in the specimen as 
documented by Samuel et  al. in their multicenter study 
on the incidence of Gram stain errors [7]. The growing 
trend of consolidation of microbiology laboratories mean 
that many hospitals are left without dedicated microbiol-
ogy staff [8]. The majority of Gram stains continue to be 
performed by microbiologists at centralized laboratories, 
however, the need for stat Gram stains at satellite facili-
ties when the information is needed for immediate inter-
vention such as suspected cases of bacterial meningitis or 
intraoperative biopsies mean that this burden now falls 
on local laboratory staff. The limited volume of specimens 
for Gram stains processed by laboratory staff at these sites 
makes it challenging to develop proficiency in Gram stain 
interpretation. Errors in Gram stain interpretation are 
more likely to occur at such satellite laboratories and the 
clinical consequences can be significant [9, 10]. While reg-
ulatory bodies use proficiency specimens to gauge labora-
tory performance on Gram stains, these do not adequately 
measure performance nor do they serve to address gaps in 
proficiency [10, 11].
In an attempt to improve Gram stain performance, 
Guarner and colleagues describe in this issue of Clini-
cal Chemistry and Laboratory Medicine the develop-
ment of an alternative bimonthly Gram stain proficiency 
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challenge to complement the existing regimen [12]. This 
included staining and review of multiple slides from the 
central laboratory by technologists followed by both 
individual and group review of challenge results. Over 
the course of the study, they were able to demonstrate 
significantly improved performance in reporting of both 
Gram stain tinctorial characteristics as well as bacterial 
morphology. While other studies have advocated routine 
review by the central laboratory of Gram stains performed 
by the satellite laboratories [11], Guarner et al. were able 
to improve technologist performance to the point where 
routine review could be limited to once daily. This in turn 
reduces the burden on core laboratories to monitor per-
formance of the satellites. The use of visual aids for Gram 
stain education is fairly common. By coupling these with 
regular individual and group review of commonly occur-
ring Gram stain errors, Guarner and colleagues appear to 
have addressed the problems caused by low frequency 
of Gram stain performance. This also includes ensuring 
that technologists have the opportunity to participate 
in staining and smear interpretation as part of the pro-
ficiency testing process. The use of digital images or pre-
stained slides alone for Gram stain proficiency limits the 
ability of the process to address gaps in the technologist 
ability to correctly fix and stain slides prior to interpre-
tation. Each step add its own challenges to the process 
and failure to correctly follow protocol at any stage makes 
accurate interpretation of smears even more difficult. 
Quality improvement efforts need to address errors at 
all stages of the process. Targeting errors in the analyti-
cal phase of both surgical pathology and microbiology 
can be challenging due to the subjective nature of the 
work and the number of variables involved. The limited 
number of Gram stains performed by satellite labora-
tories and the failure of proficiency regimens to mimic 
actual patient specimens means that the responsibility 
falls on central laboratories to adequately train satellite 
laboratory staff. The effectiveness of the Gram stain as 
a diagnostic tool is incumbent on clinicians confidence 
in the quality of the result and willingness to act on the 
result rather than wait for a culture report. Guarner et al. 
used a multipronged approach combining proficiency 
challenges with educational huddles and visual tools to 
effectively reduce the error rates in a sustainable manner. 
The collaboration of central and satellite laboratories in 
this combined effort was crucial to this process. In the era 
of laboratory consolidation, the lessons learned here can 
prove to be invaluable for other laboratories that struggle 
to maintain Gram stain proficiency.
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